Company Overview and News

1
Notice to the Holders of the Preferred Securities

2018-04-10 globenewswire
LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP I SECURITIES

 
The Last Days of Whitney Tilson's Kase Capital | Institutional Investor's Alpha

2018-04-10 institutionalinvestorsalpha
The hedge fund founder explains why his fund was "sucking the joy" out of his life -- and why he's turning its failure into a teachable moment.

 
Weekly Commentary: Market Realities

2018-04-07 seekingalpha
Markets have grown well-versed at disregarding structural issues. I'm still amazed at what the marketplace was willing to ignore throughout the mortgage finance bubble period: A doubling of mortgage credit in just about six years; California's housing market out of control by 2005; $1.0 trillion of subprime CDS in 2006; the unprecedented growth in leveraged securities holdings and so on. Unrelenting trade and current account deficits.

 
Deutsche Bank is said under pressure to resolve CEO fate

2018-04-07 livemint
London/Frankfurt: Deutsche Bank AG chairman Paul Achleitner is facing intense pressure to clarify the future of chief executive officer John Cryan within days, according to a person familiar with the inside workings of the bank.

 
Deutsche Bank Is Under Pressure to Resolve CEO’s Fate in Days - Bloomberg

2018-04-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Wall Street’s Big Banks Are Waging a Technological Arms Race - Bloomberg

2018-04-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Baupost partner at risk of jail over tax on Paris deal - Independent.ie

2018-03-29 independent.ie
Baupost Group made a tidy profit when the hedge fund bought property northwest of Paris for about $21m, revamped it, and sold it on to Gecina SA for about $475m just 20 months later.

 
Powell’s Fed Debut Shows Shift Away From Theory, Models - Bloomberg

2018-03-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
War for Asia talent pushes banks to improve plans to retain women

2018-03-21 bworldonline
YEP, THERE’S STILL plenty of long hours, hard work and heavy travel. But global investment banks in Asia that want to retain and promote women have been offering more incentives for them to return to work and stay in senior jobs — and bumping up the numbers of women in their management ranks as a result.

 
The Last Days of Whitney Tilson's Kase Capital | Institutional Investor's Alpha

2018-03-21 institutionalinvestorsalpha
The hedge fund founder explains why his fund was "sucking the joy" out of his life -- and why he's turning its failure into a teachable moment.

 
From a $126 Million Bonus to Jail: The Fall of a Star Trader - Bloomberg

2018-03-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
War for Asia Talent Pushes Banks to Boost Plans to Retain Women - Bloomberg

2018-03-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
News Live: CBI moves HC against acquittal of Raja, Kanimozhi in 2G spectrum case

2018-03-19 moneycontrol
Rajan says India needs to grow at 10% to provide jobs, wants major reforms in land buyout process

 
News Live: Lemon Tree to open 28 new hotels, to raise Rs 1,000cr via IPO

2018-03-19 moneycontrol
Rajan says India needs to grow at 10% to provide jobs, wants major reforms in land buyout process

 
News Live: Karnataka approves separate religion status for Lingayats

2018-03-19 moneycontrol
Rajan says India needs to grow at 10% to provide jobs, wants major reforms in land buyout process

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 524ESC100